Transformation of a myeloproliferative neoplasm to a secondary acute myeloid leukemia is rare but devastating. Single-cell, multi-omic characterization of hematopoietic stem and progenitor cells now shows the role of inflammation in transformation driven by mutations in TP53, with effects on the mutant clone but also non-mutant counterparts.
References
Rampal, R. et al. Proc. Natl Acad. Sci. USA 111, E5401–E5410 (2014).
Dunbar, A. J., Rampal, R. K. & Levine, R. Blood 136, 61–70 (2020).
Lundberg, P. et al. Blood 123, 2220–2228 (2014).
Kubesova, B. et al. Leukemia 32, 450–461 (2018).
Bernard, E. et al. Nat. Med. 26, 1549–1556 (2020).
Luque Paz, D. et al. Blood Adv. 4, 4887–4897 (2020).
Rodriguez-Meira, A. et al. Nat. Genet. https://doi.org/10.1038/s41588-023-01480-1 (2023).
Rodriguez-Meira, A. et al. Mol. Cell 73, 1292–1305.e8 (2019).
Mesa, R. A. et al. Blood 105, 973–977 (2005).
Walter, D. et al. Nature 520, 549–552 (2015).
Tefferi, A. Am. J. Hematol. 96, 145–162 (2021).
Stubbins, R. J., Platzbecker, U. & Karsan, A. Blood 140, 1067–1074 (2022).
Nam, A. S. et al. Nature 571, 355–360 (2019).
Van Egeren, D. et al. Cell Stem Cell 28, 514–523.e9 (2021).
Myers, R. M. et al. Preprint at bioRxiv https://doi.org/10.1101/2022.05.11.491515 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Benabid, A., Schneider, R.K. Inflammation drives pressure on TP53 mutant clones in myeloproliferative neoplasms. Nat Genet 55, 1432–1434 (2023). https://doi.org/10.1038/s41588-023-01479-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-023-01479-8
- Springer Nature America, Inc.